RISK-FACTORS FOR ACCELERATED ATHEROSCLEROSIS IN RENAL-TRANSPLANT RECIPIENTS

被引:354
作者
KASISKE, BL
机构
关键词
D O I
10.1016/0002-9343(88)90302-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:985 / 992
页数:8
相关论文
共 30 条
  • [1] ALONSO DR, 1977, AM J PATHOL, V87, P415
  • [2] THE IMPACT OF CYCLOSPORINE AND COMBINATION IMMUNOSUPPRESSION ON THE INCIDENCE OF POSTTRANSPLANT DIABETES IN RENAL-ALLOGRAFT RECIPIENTS
    BOUDREAUX, JP
    MCHUGH, L
    CANAFAX, DM
    ASCHER, N
    SUTHERLAND, DER
    PAYNE, W
    SIMMONS, RL
    NAJARIAN, JS
    FRYD, DS
    [J]. TRANSPLANTATION, 1987, 44 (03) : 376 - 381
  • [3] COX DR, 1972, J R STAT SOC B, V34, P187
  • [4] EPIDEMIOLOGY OF ATHEROSCLEROSIS - AN UPDATED OVERVIEW
    CRIQUI, MH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (05) : C18 - C23
  • [5] HYPERTENSION AND KIDNEY-TRANSPLANTATION
    CURTIS, JJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1986, 7 (03) : 181 - 196
  • [6] DIXON WJ, 1985, BMDP STATISTICAL SOF
  • [7] ALTERATIONS IN LIPID AND CARBOHYDRATE-METABOLISM ATTRIBUTABLE TO CYCLOSPORINE-A IN RENAL-TRANSPLANT RECIPIENTS
    HARRIS, KPG
    RUSSELL, GI
    PARVIN, SD
    VEITCH, PS
    WALLS, J
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1986, 292 (6512): : 16 - 16
  • [8] HESS ML, 1983, CIRCULATION, V68, P94
  • [9] HEULE H, 1981, SCHWEIZ MED WOCHENSC, V20, P709
  • [10] THE OPTIMAL ANTITHROMBOTIC DOSE OF ASPIRIN
    HIRSH, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (09) : 1582 - 1583